Takeda Pharmaceutical Co Ltd ADR Capital Reinvestment Ratio
Takeda Pharmaceutical Co Ltd ADR capital reinvestment ratio. Takeda Pharmaceutical Co Ltd ADR (TAK) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow ($360.04 Billion) in capital expenditures ($42.57 Billion). Check Takeda Pharmaceutical Co Ltd ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Capital reinvestment ratio of Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. This chart tracks Takeda Pharmaceutical Co Ltd ADR's Capital Reinvestment Ratio across 26 annual periods. Also explore Takeda Pharmaceutical Co Ltd ADR equity growth rate to track the company's year-over-year net asset growth rate.
Takeda Pharmaceutical Co Ltd ADR Capital Reinvestment Ratio by Year (2000–2025)
Takeda Pharmaceutical Co Ltd ADR capital reinvestment ratio by year from 2000 to 2025. For the full cash flow conversion analysis, see Takeda Pharmaceutical Co Ltd ADR operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $1.06 Trillion | $200.79 Billion | ▼ -71.7% |
| 2024 | 0.67x | $716.34 Billion | $480.73 Billion | ▲ +3.5% |
| 2023 | 0.65x | $977.16 Billion | $633.69 Billion | ▲ +291.5% |
| 2022 | 0.17x | $1.12 Trillion | $186.04 Billion | ▼ -29.2% |
| 2021 | 0.23x | $1.01 Trillion | $236.47 Billion | ▼ -28.0% |
| 2020 | 0.33x | $669.75 Billion | $217.71 Billion | ▼ -20.4% |
| 2019 | 0.41x | $328.48 Billion | $134.11 Billion | ▲ +20.3% |
| 2018 | 0.34x | $377.85 Billion | $128.26 Billion | ▼ -20.8% |
| 2017 | 0.43x | $261.36 Billion | $112.03 Billion | ▼ -87.1% |
| 2016 | 3.33x | $25.49 Billion | $84.86 Billion | ▲ +458.9% |
| 2015 | 0.60x | $182.52 Billion | $108.72 Billion | ▲ +12.5% |
| 2014 | 0.53x | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $158.96 Billion | $35.42 Billion | — |